A. Kuo

发表

Structural basis of interaction between urokinase-type plasminogen activator and its receptor.

D. Shaw, J. Lubkowski, A. Mazar, 2006, Journal of molecular biology.

Structure of Human Urokinase Plasminogen Activator in Complex with Its Receptor

D. Shaw, C. Bian, A. Mazar, 2006, Science.

Phosphate-enhanced transfection of cationic lipid-complexed mRNA and plasmid DNA.

K. Karikó, E. Barnathan, A. Kuo, 1998, Biochimica et biophysica acta.

Targeting of antibody-conjugated plasminogen activators to the pulmonary vasculature.

V. Muzykantov, A. Fisher, S. Danilov, 1996, The Journal of pharmacology and experimental therapeutics.

Endothelial cells internalize monoclonal antibody to angiotensin-converting enzyme.

C. Dodia, V. Muzykantov, A. Fisher, 1996, The American journal of physiology.

Endothelial targeting of a recombinant construct fusing a PECAM-1 single-chain variable antibody fragment (scFv) with prourokinase facilitates prophylactic thrombolysis in the pulmonary vasculature.

V. Muzykantov, B. Ding, D. Cines, 2005, Blood.

The kringle stabilizes urokinase binding to the urokinase receptor.

A. Mazar, D. Cines, K. Bdeir, 2003, Blood.

Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation.

V. Muzykantov, J. Atkinson, M. Poncz, 2010, Blood.

Urokinase receptor-dependent upregulation of smooth muscle cell adhesion to vitronectin by urokinase.

E. Barnathan, A. Kuo, A. Chang, 1998, Arteriosclerosis, thrombosis, and vascular biology.

Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and messenger RNA.

D. Weiner, L. Rosenfeld, J. Henkin, 1990, Blood.

Differential expression of functional protease-activated receptor-2 (PAR-2) in human vascular smooth muscle cells.

J. Hoxie, L. Brass, E. Barnathan, 1998, Arteriosclerosis, Thrombosis and Vascular Biology.

Tissue factor regulates plasminogen binding and activation.

I. Chaiken, D. Cines, P. Larson, 1998, Blood.

Novel Interactions between Urokinase and Its Receptor*

J. Weisel, A. Mazar, K. Bdeir, 2000, The Journal of Biological Chemistry.

Endocytosis of urokinase-plasminogen activator inhibitor type 1 complexes bound to a chimeric transmembrane urokinase receptor.

H. Li, D. Cines, D. Strickland, 1994, The Journal of biological chemistry.

Single-chain urokinase alone or complexed to its receptor in tetracycline-induced pleuritis in rabbits.

W. Hadden, A. Mazar, D. Cines, 2002, American journal of respiratory and critical care medicine.

Stimulatory effect of unsaturated fatty acids on the level of plasminogen activator inhibitor‐1 mRNA in cultured human endothelial cells

K. Karikó, E. Barnathan, A. Kuo, 1995, FEBS letters.

Sustained inhibition of intimal thickening. In vitro and in vivo effects of polymeric beta-cyclodextrin sulfate.

E. Barnathan, J. Tomaszewski, A. Kuo, 1995, The Journal of clinical investigation.

Tissue-type plasminogen activator binding to human endothelial cells. Evidence for two distinct binding sites.

D. Cines, K. McCrae, E. Barnathan, 1988, The Journal of biological chemistry.

The functional effects of biotinylation of anti-angiotensin-converting enzyme monoclonal antibody in terms of targeting in vivo.

V. Muzykantov, A. Fisher, A. Reinecke, 1995, Analytical biochemistry.

Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line.

D. Cines, K. Karikó, E. Barnathan, 1993, Cancer research.

Critical Role of Integrin α5β1 in Urokinase (uPA)/Urokinase Receptor (uPAR, CD87) Signaling*

R. Czekay, A. Mazar, Y. Takada, 2003, Journal of Biological Chemistry.

Crystallization of soluble urokinase receptor (suPAR) in complex with urokinase amino-terminal fragment (1-143).

A. Mazar, Mingdong Huang, D. Cines, 2005, Acta crystallographica. Section D, Biological crystallography.

Determinants of binding and internalization of tissue-type plasminogen activator by human vascular smooth muscle and endothelial cells.

D. Cines, S. Grobmyer, E. Barnathan, 1993, The Journal of biological chemistry.

Binding of Urokinase Plasminogen Activator to gp130 via a Putative Urokinase-Binding Consensus Sequence

K. Preissner, O. Liang, K. Bdeir, 2003, Biological chemistry.

From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 23, 2013. For personal use only.

D. Eslin, D. Cines, K. Bdeir, 2002 .

Regulation of the single-chain urokinase-urokinase receptor complex activity by plasminogen and fibrin: novel mechanism of fibrin specificity.

D. Cines, A. Higazi, A. Kuo, 2005, Blood.

Heparin enhances active site-dependent binding of tissue-type plasminogen activator to endothelial cells

J. Hirsh, L. Rosenfeld, D. Cines, 1992 .

Heparin enhances active site-dependent binding of tissue-type plasminogen activator to endothelial cells.

J. Hirsh, L. Rosenfeld, D. Cines, 1992, Blood.

Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.

L. Rosenfeld, J. Henkin, D. Cines, 1990, The Journal of biological chemistry.

Tissue Factor Regulates Plasminogen Binding and Activation

I. Chaiken, D. Cines, A. Higazi, 1998 .

Urokinase‐derived peptides regulate vascular smooth muscle contraction in vitro and in vivo

A. Al-Mehdi, A. Mazar, D. Cines, 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Overexpression of urokinase receptor in mammalian cells following administration of the in vitro transcribed encoding mRNA

K. Karikó, E. Barnathan, A. Kuo, 1999, Gene Therapy.

facilitates prophylactic thrombolysis in the pulmonary vasculature single-chain variable antibody fragment (scFv) with pro-urokinase Endothelial targeting of a recombinant construct fusing a PECAM-1

V. Muzykantov, B. Ding, D. Cines, 2013 .

Complexes Lysis of Plasma Clots by Urokinase-Soluble Urokinase Receptor

D. Cines, K. Bdeir, A. Higazi, 2013 .

Lysis of plasma clots by urokinase-soluble urokinase receptor complexes.

D. Cines, K. Bdeir, A. Higazi, 1998, Blood.

Lysis of plasma clots by urokinase-soluble urokinase receptor complexes.

D. Cines, K. Bdeir, A. Kuo, 1998, Blood.

Synthesis and expression of C1 inhibitor by human umbilical vein endothelial cells.

A. Schmaier, G. Heda, D. Cines, 1989, The Journal of biological chemistry.

Critical role of integrin alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling.

R. Czekay, A. Mazar, Y. Takada, 2003, The Journal of biological chemistry.

Detection of endothelial cell‐reactive immunoglobulin in patients with anti‐phospholipid antibodies

A. DeMichele, K. McCrae, A. Kuo, 1991, British journal of haematology.

The expression of high molecular weight kininogen on human umbilical vein endothelial cells.

A. Schmaier, D. Cines, A. Kuo, 1988, The Journal of biological chemistry.

Antithrombotic thrombocytes: ectopic expression of urokinase-type plasminogen activator in platelets.

D. Eslin, M. Poncz, D. Cines, 2003, Blood.

Binding of Urokinase to Low Density Lipoprotein-related Receptor (LRP) Regulates Vascular Smooth Muscle Cell Contraction*

A. Mazar, D. Cines, K. Bdeir, 2002, The Journal of Biological Chemistry.

Nuclear translocation of urokinase-type plasminogen activator.

M. Marks, V. Tkachuk, D. Cines, 2008, Blood.

Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.

J. Hoxie, D. Cines, K. Karikó, 1993, Circulation research.

cell surface endocytic itinerary, resulting in retention of low-density lipoprotein on the Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the

M. Poncz, K. Williams, D. Cines, 2013 .

Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic machinery, resulting in retention of low-density lipoprotein on the cell surface.

M. Poncz, K. Williams, D. Cines, 2002, Blood.

Mapping the Interaction between High Molecular Mass Kininogen and the Urokinase Plasminogen Activator Receptor*

A. Schmaier, D. Cines, A. Kuo, 2004, Journal of Biological Chemistry.

Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin αvβ3 induces signal transduction and enhances plasminogen activation

J. Takagi, A. Mazar, Y. Takada, 2006, Thrombosis and Haemostasis.

A Region in Domain II of the Urokinase Receptor Required for Urokinase Binding*

A. Mazar, D. Cines, K. Bdeir, 2000, The Journal of Biological Chemistry.

Defensin promotes the binding of lipoprotein(a) to vascular matrix.

M. Koschinsky, J. Weisel, T. Ganz, 1999, Blood.

of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin induces signal transduction and enhances plasminogen activation.

J. Takagi, A. Mazar, Y. Takada, 2006 .

Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.

J. Takagi, A. Mazar, Y. Takada, 2006, Thrombosis and haemostasis.

Invasive neoplastic uroepithelial cells express high-levels of urokinase receptor and plasminogen receptor, alpha-enolase.

K. Karikó, E. Barnathan, A. Kuo, 1993, International journal of oncology.

Targeting of a Mutant Plasminogen Activator to Circulating Red Blood Cells for Prophylactic Fibrinolysis

Vladimir R Muzykantov, Mortimer Poncz, V. Muzykantov, 2010, Journal of Pharmacology and Experimental Therapeutics.

Native Atherosclerosis and Vein Graft Arterialization: Association with Increased Urokinase Receptor Expression In Vitro and In Vivo

K. Karikó, E. Barnathan, A. Kuo, 1998, Thrombosis and Haemostasis.

Variability in the expression of urokinase receptor (CD87) mutants on cells: relevance to cell adhesion

K. Preissner, D. Cines, K. Bdeir, 2004, Cell biochemistry and function.

Inhibition of human vascular smooth muscle cell migration and proliferation by beta-cyclodextrin tetradecasulfate.

P. B. Weisz, E. Barnathan, A. Kuo, 1995, The Journal of pharmacology and experimental therapeutics.

Nuclear Translocation of Urokinase-type Plasminogen Activator Lentivirus-based Nucleolin Rna Interference

D. Cines, K. Bdeir, S. Tkachuk, 2022 .

Targeting of a Mutant Plasminogen Activator to Circulating Red Blood Cells for Prophylactic Fibrinolysis

V. Muzykantov, J. Atkinson, M. Poncz, 2010, Journal of Pharmacology and Experimental Therapeutics.